IAA12 Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
IAA12 antibody; Os03g0633800 antibody; LOC_Os03g43410 antibody; OsJ_11822 antibody; OSJNBa0010N03.16Auxin-responsive protein IAA12 antibody; Indoleacetic acid-induced protein 12 antibody
Target Names
IAA12
Uniprot No.

Target Background

Function
Aux/IAA proteins are short-lived transcriptional factors that function as repressors of early auxin response genes at low auxin concentrations.
Database Links

KEGG: osa:4333512

STRING: 39947.LOC_Os03g43410.1

UniGene: Os.9945

Protein Families
Aux/IAA family
Subcellular Location
Nucleus.
Tissue Specificity
Expressed in etiolated shoots and roots.

Q&A

How should researchers select appropriate IAA12 antibodies for immunolocalization studies?

When selecting IAA12 antibodies for immunolocalization, consider antibodies specifically raised against Arabidopsis thaliana IAA12 (UniProt: Q38830). Commercial options include polyclonal antibodies like CSB-PA658509XA01DOA . For optimal results:

  • Verify reactivity with Arabidopsis thaliana specifically

  • Validate antibody specificity using Western blots comparing wild-type and iaa12 mutant tissues

  • Perform immunoprecipitation followed by mass spectrometry to confirm specificity

  • Consider generating custom antibodies against unique IAA12 epitopes if commercial options show cross-reactivity with other Aux/IAA family members

What are the recommended protocols for IAA12 immunolocalization in plant tissues?

Based on established protocols for IAA immunolocalization, the following methodology can be adapted for IAA12:

  • Fix plant tissue in 4% EDAC (1-Ethyl-3-(3-dimethyl-aminopropyl)-carbodiimide hydrochloride) in MTSB buffer for 20 minutes

  • Post-fix in 4% EDAC with 2% formaldehyde for 30 minutes to preserve protein localization and tissue integrity

  • Embed tissue in paraffin or resin for sectioning

  • Block with 3% BSA in PBS with 0.1% Triton X-100

  • Incubate with primary IAA12 antibody at dilutions between 1:100-1:600

  • Use fluorescent-conjugated secondary antibodies (e.g., DyLight 549) at 1:3000 dilution

  • Include appropriate controls: pre-immune serum, secondary antibody-only, and peptide competition controls

How can researchers distinguish between IAA12 and other closely related Aux/IAA proteins?

IAA12 belongs to a family of 29 Aux/IAA proteins in Arabidopsis, with particularly close homology to IAA13 . To ensure specificity:

  • Target unique regions of IAA12 that differ from IAA13 and other family members when generating antibodies

  • Perform Western blot analysis on recombinant IAA12, IAA13, and other closely related family members to assess cross-reactivity

  • Validate antibody specificity in iaa12 knockout/knockdown lines

  • Compare immunolocalization patterns with those of IAA12-GFP fusion proteins expressed from native promoters

  • Use double-labeling experiments with antibodies against known IAA12-interacting proteins like ARF7

What dilution ratios should be used for IAA12 antibodies in different applications?

Based on established protocols for plant antibodies:

ApplicationRecommended Dilution RangeNotes
Immunolocalization1:100 - 1:600Higher concentrations may be needed for fixed tissues
Western blot1:1,000 - 1:5,000Optimize based on antibody sensitivity and protein abundance
ELISA1:5,000 - 1:10,000Higher dilutions suitable for quantitative assays
Co-immunoprecipitation1:200 - 1:500Lower dilutions to ensure sufficient capture
ChIP1:100 - 1:250Optimize for crosslinked chromatin

Always perform titration experiments to determine optimal dilutions for specific antibody lots and experimental conditions.

How can IAA12 antibodies be used to study IAA12 nucleo-cytoplasmic translocation?

Recent research has revealed that IAA12 undergoes dynamic nucleo-cytoplasmic translocation in response to environmental stresses . To study this:

  • Perform cellular fractionation to separate nuclear and cytoplasmic compartments:

    • Homogenize plant tissues in fractionation buffer containing protease inhibitors

    • Separate nuclear and cytoplasmic fractions via differential centrifugation

    • Verify fraction purity using nuclear (histone H3) and cytoplasmic (GAPDH) markers

    • Analyze IAA12 distribution using Western blotting with IAA12 antibodies

  • For in situ visualization:

    • Perform immunolocalization under various stress conditions (PEG, mannitol, NaCl)

    • Quantify nuclear vs. cytoplasmic signal intensity across multiple cells

    • Compare IAA12 localization in wild-type vs. cpr5 mutant and CPR5-overexpressing lines

    • Use confocal microscopy with z-stack acquisition for 3D localization analysis

How can researchers study IAA12-ARF7 interactions using antibodies?

IAA12 regulates auxin responses by interacting with ARF7 transcription factors . To investigate this interaction:

  • Co-immunoprecipitation approach:

    • Immunoprecipitate IAA12 using anti-IAA12 antibodies from plant extracts

    • Probe Western blots with anti-ARF7 antibodies to detect interaction

    • Perform reciprocal IP with anti-ARF7 antibodies

    • Include controls: IgG control, input samples, and samples treated with or without auxin

  • Proximity ligation assay (PLA) for in situ detection:

    • Use primary antibodies against IAA12 and ARF7 from different host species

    • Apply species-specific secondary antibodies conjugated to complementary oligonucleotides

    • Visualize interaction as fluorescent spots only where proteins are in close proximity

    • Quantify interaction signals in different cell types and conditions

How do CPR5 mutations affect IAA12 localization, and how can this be studied with antibodies?

CPR5 (CONSTITUTIVE EXPRESSOR OF PATHOGENESIS-RELATED) mediates nucleo-cytoplasmic distribution of IAA12 . To study this relationship:

  • Compare IAA12 localization in wild-type, cpr5 mutant, and CPR5-overexpressing lines:

    • In wild-type roots, IAA12 is nuclear in the meristem region but gradually accumulates in the cytoplasm in the elongation zone

    • In cpr5 mutants, IAA12 remains exclusively nuclear even in the elongation zone

    • In CPR5-overexpressing lines, IAA12 is predominantly cytoplasmic throughout the root

  • Combine antibody-based detection with nuclear/cytoplasmic fractionation:

    • Isolate root tips from different genotypes

    • Separate nuclear and cytoplasmic fractions

    • Quantify IAA12 distribution via Western blotting and densitometry

    • Compare protein distribution ratios across genotypes

How can researchers study IAA12 protein stability in response to auxin using antibodies?

IAA12 has a longer half-life compared to other Aux/IAA proteins but is still degraded after auxin treatment . To study protein stability:

  • Time-course experiments:

    • Treat plant tissues with auxin and cycloheximide (to block new protein synthesis)

    • Harvest samples at different timepoints (0-120 minutes)

    • Perform Western blotting with IAA12 antibodies

    • Quantify protein levels and calculate half-life

  • Compare IAA12 stability in different subcellular compartments:

    • Perform nuclear/cytoplasmic fractionation after auxin treatment

    • Compare degradation rates in each compartment

    • Investigate whether IAA12-NES (nuclear export signal) fusions show altered stability compared to IAA12-NLS (nuclear localization signal) fusions

How can researchers reconcile differences between IAA12-GFP fusion data and antibody-based detection?

When comparing IAA12-GFP localization patterns with antibody-based detection:

  • Consider potential artifacts:

    • GFP tags (27 kDa) may alter IAA12 localization, interactions, or function

    • Antibody accessibility might be affected by protein interactions or conformational changes

    • Fixation procedures may alter protein localization

  • Validation approaches:

    • Verify that IAA12-GFP complements iaa12 mutant phenotypes

    • Compare IAA12-GFP, IAA12-Venus, and IAA12-HA tagged proteins for consistent localization

    • Use multiple antibodies targeting different IAA12 epitopes

    • Employ cellular fractionation followed by Western blotting as an independent method

What controls are essential when using IAA12 antibodies for experimental studies?

To ensure reliable results with IAA12 antibodies:

  • Specificity controls:

    • Compare signal in wild-type vs. iaa12 mutant tissues

    • Perform peptide competition assays to confirm epitope specificity

    • Test cross-reactivity with recombinant IAA12 and related proteins (especially IAA13)

  • Technical controls:

    • Include secondary antibody-only controls to assess background

    • Use pre-immune serum controls

    • For co-IP experiments, include IgG controls and single-transfection controls

    • For immunolocalization, include both positive (known expression domains) and negative (non-expressing tissues) controls

How should researchers interpret IAA12 localization changes during plant development and stress responses?

IAA12 shows dynamic relocalization during development and in response to stress . When interpreting these changes:

  • Developmental context:

    • IAA12 is nuclear in meristem cells but gradually accumulates in the cytoplasm in the elongation zone under normal conditions

    • This pattern suggests developmental regulation of nuclear import/export machinery

  • Stress responses:

    • Abiotic stresses (PEG, mannitol, NaCl) trigger IAA12 nuclear accumulation in the elongation zone

    • This relocalization appears to suppress auxin responses required for lateral root development

    • Consider these changes in relation to known auxin signaling outputs and developmental phenotypes

  • Quantification approaches:

    • Measure nuclear/cytoplasmic signal ratios across multiple cells and biological replicates

    • Correlate localization changes with auxin-responsive gene expression changes

    • Compare with other Aux/IAA family members to identify protein-specific vs. general responses

What methodological considerations are important when studying IAA12-ARF interactions?

IAA12 interacts with ARF7 to regulate auxin responses . When investigating this interaction:

  • Consider protein abundance:

    • IAA12 is typically low-abundance and requires sensitive detection methods

    • Overexpression systems may not reflect physiological interactions

    • Use native promoter-driven constructs when possible

  • Interaction dynamics:

    • Auxin treatment affects IAA12-ARF7 interaction by promoting IAA12 degradation

    • CPR5 decreases IAA12-ARF7 interaction by promoting IAA12 nuclear export

    • Time-course experiments may be necessary to capture transient interactions

  • Functional validation:

    • Correlate protein interactions with auxin-responsive gene expression (e.g., using GH3pro:LUC reporter)

    • Compare wild-type IAA12 with modified versions (IAA12-NLS, IAA12-NES) to determine the functional importance of localization

    • Use domain mutants to map specific interaction interfaces

How can IAA12 antibodies contribute to understanding the specificity of auxin response pathways?

The Arabidopsis genome encodes 22 ARF and 29 Aux/IAA proteins, creating potential for over 600 possible pairwise combinations . IAA12 antibodies can help elucidate specificity mechanisms:

  • Tissue-specific expression patterns:

    • Map IAA12 protein distribution across development using immunohistochemistry

    • Compare with transcriptional data to identify post-transcriptional regulation

    • Analyze co-expression with specific ARF partners

  • Protein-protein interaction networks:

    • Use IAA12 antibodies for immunoprecipitation followed by mass spectrometry

    • Identify tissue-specific interaction partners beyond ARFs

    • Compare IAA12 and IAA13 interactomes to understand functional redundancy and specificity

  • Signaling dynamics:

    • Track IAA12 levels and localization during developmental transitions

    • Correlate with auxin response outputs to develop mathematical models of signaling specificity

    • Compare multiple Aux/IAA family members under identical conditions

How can researchers use IAA12 antibodies to study its role in chromatin regulation?

Since IAA12 regulates transcription through ARF interactions, chromatin immunoprecipitation (ChIP) approaches can reveal genome-wide impacts:

  • ChIP approach:

    • Crosslink plant tissues to preserve protein-DNA interactions

    • Immunoprecipitate IAA12 using specific antibodies

    • Identify associated DNA regions via sequencing or qPCR

    • Compare binding sites with ARF7 ChIP profiles

  • Chromatin accessibility:

    • Combine IAA12 ChIP with ATAC-seq to correlate binding with chromatin state changes

    • Use wild-type plants versus those with altered IAA12 (mutants, overexpression)

    • Map changes in chromatin organization to auxin-responsive genes

What approaches can resolve contradictions between IAA12 transcriptional and post-translational regulation data?

To reconcile different regulatory levels:

  • Integrated approaches:

    • Simultaneously analyze IAA12 mRNA (RT-PCR), protein levels (Western blot), and localization (immunohistochemistry) in the same samples

    • Track dynamic changes during development and stress responses

    • Compare turnover rates of mRNA versus protein

  • Reporter systems:

    • Compare transcriptional (IAA12pro:GUS) versus translational (IAA12pro:IAA12-GUS) reporters

    • Use inducible expression systems to separate transcriptional from post-translational effects

    • Employ ribosome profiling to assess translation efficiency

  • Mathematical modeling:

    • Develop models incorporating transcription, translation, protein stability, and localization

    • Use experimental data to validate and refine models

    • Predict system behavior under perturbations and validate experimentally

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.